APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Teriflunomide Tablets Market Analysis and Forecast 2026-2032

27 December 2025200 pages

Choose your research edition.

Industry ResearchTeriflunomide Tablets Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide Tablets Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Teriflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Teriflunomide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Teriflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Teriflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Teriflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Teriflunomide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Teriflunomide Tablets include Teva, CGeneTech (Suzhou, China), Nanjing Healthnice Pharmaceutical, Mylan, Cisen Pharmaceutical, Zydus, Viatris, SOLA Pharmaceuticals and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Teriflunomide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Teriflunomide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Teriflunomide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Teriflunomide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Teriflunomide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Teriflunomide Tablets sales, projected growth trends, production technology, application and end-user industry.

Teriflunomide Tablets Segment by Company

Teva

CGeneTech (Suzhou, China)

Nanjing Healthnice Pharmaceutical

Mylan

Cisen Pharmaceutical

Zydus

Viatris

SOLA Pharmaceuticals

Sanofi

Sandoz

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Camber Pharmaceuticals

Aurobindo Pharma

Apotex

Alembic

Accord Healthcare

Teriflunomide Tablets Segment by Type

7mg per Tablet

14mg per Tablet

Teriflunomide Tablets Segment by Application

Hospital and Clinic

Pharmacy

Other

Teriflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Teriflunomide Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Teriflunomide Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Teriflunomide Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Teriflunomide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 7mg per Tablet Major Manufacturers Table 3. 14mg per Tablet Major Manufacturers Table 4. Global Teriflunomide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Teriflunomide Tablets Industry Trends Table 9. Teriflunomide Tablets Industry Drivers Table 10. Teriflunomide Tablets Industry Opportunities and Challenges Table 11. Teriflunomide Tablets Industry Restraints Table 12. Global Teriflunomide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Teriflunomide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Teriflunomide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Teriflunomide Tablets Revenue Market Share by Region (2021-2026) Table 16. Global Teriflunomide Tablets Revenue Market Share by Region (2027-2032) Table 17. Global Teriflunomide Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Teriflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 19. Global Teriflunomide Tablets Sales by Region (2027-2032) & (K Units) Table 20. Global Teriflunomide Tablets Sales Market Share by Region (2021-2026) Table 21. Global Teriflunomide Tablets Sales Market Share by Region (2027-2032) Table 22. Global Teriflunomide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Teriflunomide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Teriflunomide Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Teriflunomide Tablets Sales Market Share by Manufacturers (2021-2026) Table 26. Global Teriflunomide Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Teriflunomide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Teriflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Teriflunomide Tablets Manufacturers, Product Type & Application Table 30. Global Teriflunomide Tablets Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Teriflunomide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Teriflunomide Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2026) Table 37. Global Teriflunomide Tablets Revenue Market Share by Type (2027-2032) Table 38. Global Teriflunomide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 40. Global Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 41. Global Teriflunomide Tablets Sales Market Share by Type (2021-2026) Table 42. Global Teriflunomide Tablets Sales Market Share by Type (2027-2032) Table 43. Global Teriflunomide Tablets Price by Type (2021-2026) & (US$/Unit) Table 44. Global Teriflunomide Tablets Price by Type (2027-2032) & (US$/Unit) Table 45. Global Teriflunomide Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2026) Table 49. Global Teriflunomide Tablets Revenue Market Share by Application (2027-2032) Table 50. Global Teriflunomide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 53. Global Teriflunomide Tablets Sales Market Share by Application (2021-2026) Table 54. Global Teriflunomide Tablets Sales Market Share by Application (2027-2032) Table 55. Global Teriflunomide Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Teriflunomide Tablets Price by Application (2027-2032) & (US$/Unit) Table 57. Teva Company Information Table 58. Teva Business Overview Table 59. Teva Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Teva Teriflunomide Tablets Product Portfolio Table 61. Teva Recent Development Table 62. CGeneTech (Suzhou, China) Company Information Table 63. CGeneTech (Suzhou, China) Business Overview Table 64. CGeneTech (Suzhou, China) Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio Table 66. CGeneTech (Suzhou, China) Recent Development Table 67. Nanjing Healthnice Pharmaceutical Company Information Table 68. Nanjing Healthnice Pharmaceutical Business Overview Table 69. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio Table 71. Nanjing Healthnice Pharmaceutical Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Mylan Teriflunomide Tablets Product Portfolio Table 76. Mylan Recent Development Table 77. Cisen Pharmaceutical Company Information Table 78. Cisen Pharmaceutical Business Overview Table 79. Cisen Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio Table 81. Cisen Pharmaceutical Recent Development Table 82. Zydus Company Information Table 83. Zydus Business Overview Table 84. Zydus Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zydus Teriflunomide Tablets Product Portfolio Table 86. Zydus Recent Development Table 87. Viatris Company Information Table 88. Viatris Business Overview Table 89. Viatris Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Viatris Teriflunomide Tablets Product Portfolio Table 91. Viatris Recent Development Table 92. SOLA Pharmaceuticals Company Information Table 93. SOLA Pharmaceuticals Business Overview Table 94. SOLA Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 96. SOLA Pharmaceuticals Recent Development Table 97. Sanofi Company Information Table 98. Sanofi Business Overview Table 99. Sanofi Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sanofi Teriflunomide Tablets Product Portfolio Table 101. Sanofi Recent Development Table 102. Sandoz Company Information Table 103. Sandoz Business Overview Table 104. Sandoz Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Sandoz Teriflunomide Tablets Product Portfolio Table 106. Sandoz Recent Development Table 107. Glenmark Pharmaceuticals Company Information Table 108. Glenmark Pharmaceuticals Business Overview Table 109. Glenmark Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 111. Glenmark Pharmaceuticals Recent Development Table 112. Dr. Reddy's Laboratories Company Information Table 113. Dr. Reddy's Laboratories Business Overview Table 114. Dr. Reddy's Laboratories Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio Table 116. Dr. Reddy's Laboratories Recent Development Table 117. Camber Pharmaceuticals Company Information Table 118. Camber Pharmaceuticals Business Overview Table 119. Camber Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 121. Camber Pharmaceuticals Recent Development Table 122. Aurobindo Pharma Company Information Table 123. Aurobindo Pharma Business Overview Table 124. Aurobindo Pharma Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Aurobindo Pharma Teriflunomide Tablets Product Portfolio Table 126. Aurobindo Pharma Recent Development Table 127. Apotex Company Information Table 128. Apotex Business Overview Table 129. Apotex Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Apotex Teriflunomide Tablets Product Portfolio Table 131. Apotex Recent Development Table 132. Alembic Company Information Table 133. Alembic Business Overview Table 134. Alembic Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Alembic Teriflunomide Tablets Product Portfolio Table 136. Alembic Recent Development Table 137. Accord Healthcare Company Information Table 138. Accord Healthcare Business Overview Table 139. Accord Healthcare Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Accord Healthcare Teriflunomide Tablets Product Portfolio Table 141. Accord Healthcare Recent Development Table 142. North America Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 145. North America Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 146. North America Teriflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 147. North America Teriflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 148. North America Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 151. North America Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 152. North America Teriflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 153. North America Teriflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 154. North America Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Teriflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Teriflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. North America Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 159. North America Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 160. North America Teriflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 161. North America Teriflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 162. United States Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 163. Canada Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 164. Mexico Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 165. Europe Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 168. Europe Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 169. Europe Teriflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Europe Teriflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Europe Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 174. Europe Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 175. Europe Teriflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Europe Teriflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Europe Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Teriflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Teriflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 181. Europe Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 182. Europe Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 183. Europe Teriflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Europe Teriflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Germany Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 186. France Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 187. U.K. Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 188. Italy Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 189. Russia Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 190. Spain Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 193. Sweden Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 194. Poland Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 195. China Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 196. China Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 197. China Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 198. China Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 199. China Teriflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 200. China Teriflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 201. China Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 202. China Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 203. China Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 204. China Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 205. China Teriflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 206. China Teriflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 210. Asia Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 211. Asia Teriflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 212. Asia Teriflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 213. Asia Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 216. Asia Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 217. Asia Teriflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 218. Asia Teriflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 219. Asia Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Teriflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Teriflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 223. Asia Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 224. Asia Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 225. Asia Teriflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 226. Asia Teriflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 227. Japan Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 228. South Korea Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 229. India Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 230. Australia Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Teriflunomide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Teriflunomide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Teriflunomide Tablets Sales by Type (2021-2026) & (K Units) Table 236. SAMEA Teriflunomide Tablets Sales by Type (2027-2032) & (K Units) Table 237. SAMEA Teriflunomide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 238. SAMEA Teriflunomide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 239. SAMEA Teriflunomide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Teriflunomide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Teriflunomide Tablets Sales by Application (2021-2026) & (K Units) Table 242. SAMEA Teriflunomide Tablets Sales by Application (2027-2032) & (K Units) Table 243. SAMEA Teriflunomide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 244. SAMEA Teriflunomide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 245. SAMEA Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Teriflunomide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Teriflunomide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 249. SAMEA Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 250. SAMEA Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 251. SAMEA Teriflunomide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 252. SAMEA Teriflunomide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 253. Brazil Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 254. Argentina Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 255. Chile Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 256. Colombia Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 257. Peru Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 259. Israel Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 260. UAE Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 261. Turkey Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 262. Iran Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 263. Egypt Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Teriflunomide Tablets Distributors List Table 267. Teriflunomide Tablets Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Teriflunomide Tablets Image Figure 2. Global Teriflunomide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Teriflunomide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 7mg per Tablet Image Figure 5. 14mg per Tablet Image Figure 6. Global Teriflunomide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Teriflunomide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Teriflunomide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Teriflunomide Tablets Revenue (2021-2032) & (US$ Million) Figure 13. Global Teriflunomide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Teriflunomide Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Teriflunomide Tablets Revenue Market Share by Region (2021-2032) Figure 16. Global Teriflunomide Tablets Sales (2021-2032) & (K Units) Figure 17. Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Teriflunomide Tablets Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Teriflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 20. Europe Teriflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 21. China Teriflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Teriflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Teriflunomide Tablets Sales YoY (2021-2032) & (K Units) Figure 24. Global Teriflunomide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Teriflunomide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Teriflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Teriflunomide Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032) Figure 30. Global Teriflunomide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Teriflunomide Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Teriflunomide Tablets Sales Market Share by Type (2021-2032) Figure 33. Global Teriflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Teriflunomide Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032) Figure 36. Global Teriflunomide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Teriflunomide Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Teriflunomide Tablets Sales Market Share by Application (2021-2032) Figure 39. North America Teriflunomide Tablets Revenue Share by Type (2021-2032) Figure 40. North America Teriflunomide Tablets Sales Share by Type (2021-2032) Figure 41. North America Teriflunomide Tablets Revenue Share by Application (2021-2032) Figure 42. North America Teriflunomide Tablets Sales Share by Application (2021-2032) Figure 43. North America Teriflunomide Tablets Revenue Share by Country (2021-2032) Figure 44. North America Teriflunomide Tablets Sales Share by Country (2021-2032) Figure 45. Europe Teriflunomide Tablets Revenue Share by Type (2021-2032) Figure 46. Europe Teriflunomide Tablets Sales Share by Type (2021-2032) Figure 47. Europe Teriflunomide Tablets Revenue Share by Application (2021-2032) Figure 48. Europe Teriflunomide Tablets Sales Share by Application (2021-2032) Figure 49. Europe Teriflunomide Tablets Revenue Share by Country (2021-2032) Figure 50. Europe Teriflunomide Tablets Sales Share by Country (2021-2032) Figure 51. China Teriflunomide Tablets Revenue Share by Type (2021-2032) Figure 52. China Teriflunomide Tablets Sales Share by Type (2021-2032) Figure 53. China Teriflunomide Tablets Revenue Share by Application (2021-2032) Figure 54. China Teriflunomide Tablets Sales Share by Application (2021-2032) Figure 55. Asia Teriflunomide Tablets Revenue Share by Type (2021-2032) Figure 56. Asia Teriflunomide Tablets Sales Share by Type (2021-2032) Figure 57. Asia Teriflunomide Tablets Revenue Share by Application (2021-2032) Figure 58. Asia Teriflunomide Tablets Sales Share by Application (2021-2032) Figure 59. Asia Teriflunomide Tablets Revenue Share by Country (2021-2032) Figure 60. Asia Teriflunomide Tablets Sales Share by Country (2021-2032) Figure 61. SAMEA Teriflunomide Tablets Revenue Share by Type (2021-2032) Figure 62. SAMEA Teriflunomide Tablets Sales Share by Type (2021-2032) Figure 63. SAMEA Teriflunomide Tablets Revenue Share by Application (2021-2032) Figure 64. SAMEA Teriflunomide Tablets Sales Share by Application (2021-2032) Figure 65. SAMEA Teriflunomide Tablets Revenue Share by Country (2021-2032) Figure 66. SAMEA Teriflunomide Tablets Sales Share by Country (2021-2032) Figure 67. Teriflunomide Tablets Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Teriflunomide Tablets Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 7mg per Tablet
  • 14mg per Tablet
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • CGeneTech (Suzhou, China)
  • Nanjing Healthnice Pharmaceutical
  • Mylan
  • Cisen Pharmaceutical
  • Zydus
  • Viatris
  • SOLA Pharmaceuticals
  • Sanofi
  • Sandoz
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Camber Pharmaceuticals
  • Aurobindo Pharma
  • Apotex
  • Alembic
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Teriflunomide Tablets Market by Type
  3. 1.2.1 Global Teriflunomide Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 7mg per Tablet
  5. 1.2.3 14mg per Tablet
  6. 1.3 Teriflunomide Tablets Market by Application
  7. 1.3.1 Global Teriflunomide Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Teriflunomide Tablets Market Dynamics
  1. 2.1 Teriflunomide Tablets Industry Trends
  2. 2.2 Teriflunomide Tablets Industry Drivers
  3. 2.3 Teriflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Teriflunomide Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Teriflunomide Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Teriflunomide Tablets Revenue by Region
  3. 3.2.1 Global Teriflunomide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Teriflunomide Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Teriflunomide Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Teriflunomide Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Teriflunomide Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Teriflunomide Tablets Sales by Region
  9. 3.4.1 Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Teriflunomide Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Teriflunomide Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Teriflunomide Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Teriflunomide Tablets Revenue by Manufacturers
  2. 4.1.1 Global Teriflunomide Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Teriflunomide Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Teriflunomide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Teriflunomide Tablets Sales by Manufacturers
  6. 4.2.1 Global Teriflunomide Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Teriflunomide Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Teriflunomide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Teriflunomide Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Teriflunomide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Teriflunomide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Teriflunomide Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Teriflunomide Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Teriflunomide Tablets Market CR5 and HHI
  16. 4.8.2 2025 Teriflunomide Tablets Tier 1, Tier 2, and Tier 3
5 Teriflunomide Tablets Market by Type
  1. 5.1 Global Teriflunomide Tablets Revenue by Type
  2. 5.1.1 Global Teriflunomide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Teriflunomide Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Teriflunomide Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Teriflunomide Tablets Sales by Type
  6. 5.2.1 Global Teriflunomide Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Teriflunomide Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Teriflunomide Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Teriflunomide Tablets Price by Type
6 Teriflunomide Tablets Market by Application
  1. 6.1 Global Teriflunomide Tablets Revenue by Application
  2. 6.1.1 Global Teriflunomide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Teriflunomide Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Teriflunomide Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Teriflunomide Tablets Sales by Application
  6. 6.2.1 Global Teriflunomide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Teriflunomide Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Teriflunomide Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Teriflunomide Tablets Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Teriflunomide Tablets Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 CGeneTech (Suzhou, China)
  8. 7.2.1 CGeneTech (Suzhou, China) Company Information
  9. 7.2.2 CGeneTech (Suzhou, China) Business Overview
  10. 7.2.3 CGeneTech (Suzhou, China) Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio
  12. 7.2.5 CGeneTech (Suzhou, China) Recent Developments
  13. 7.3 Nanjing Healthnice Pharmaceutical
  14. 7.3.1 Nanjing Healthnice Pharmaceutical Company Information
  15. 7.3.2 Nanjing Healthnice Pharmaceutical Business Overview
  16. 7.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio
  18. 7.3.5 Nanjing Healthnice Pharmaceutical Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Teriflunomide Tablets Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Cisen Pharmaceutical
  26. 7.5.1 Cisen Pharmaceutical Company Information
  27. 7.5.2 Cisen Pharmaceutical Business Overview
  28. 7.5.3 Cisen Pharmaceutical Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio
  30. 7.5.5 Cisen Pharmaceutical Recent Developments
  31. 7.6 Zydus
  32. 7.6.1 Zydus Company Information
  33. 7.6.2 Zydus Business Overview
  34. 7.6.3 Zydus Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zydus Teriflunomide Tablets Product Portfolio
  36. 7.6.5 Zydus Recent Developments
  37. 7.7 Viatris
  38. 7.7.1 Viatris Company Information
  39. 7.7.2 Viatris Business Overview
  40. 7.7.3 Viatris Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Viatris Teriflunomide Tablets Product Portfolio
  42. 7.7.5 Viatris Recent Developments
  43. 7.8 SOLA Pharmaceuticals
  44. 7.8.1 SOLA Pharmaceuticals Company Information
  45. 7.8.2 SOLA Pharmaceuticals Business Overview
  46. 7.8.3 SOLA Pharmaceuticals Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio
  48. 7.8.5 SOLA Pharmaceuticals Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Teriflunomide Tablets Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
  55. 7.10 Sandoz
  56. 7.10.1 Sandoz Company Information
  57. 7.10.2 Sandoz Business Overview
  58. 7.10.3 Sandoz Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sandoz Teriflunomide Tablets Product Portfolio
  60. 7.10.5 Sandoz Recent Developments
  61. 7.11 Glenmark Pharmaceuticals
  62. 7.11.1 Glenmark Pharmaceuticals Company Information
  63. 7.11.2 Glenmark Pharmaceuticals Business Overview
  64. 7.11.3 Glenmark Pharmaceuticals Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio
  66. 7.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 7.12 Dr. Reddy's Laboratories
  68. 7.12.1 Dr. Reddy's Laboratories Company Information
  69. 7.12.2 Dr. Reddy's Laboratories Business Overview
  70. 7.12.3 Dr. Reddy's Laboratories Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio
  72. 7.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 7.13 Camber Pharmaceuticals
  74. 7.13.1 Camber Pharmaceuticals Company Information
  75. 7.13.2 Camber Pharmaceuticals Business Overview
  76. 7.13.3 Camber Pharmaceuticals Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio
  78. 7.13.5 Camber Pharmaceuticals Recent Developments
  79. 7.14 Aurobindo Pharma
  80. 7.14.1 Aurobindo Pharma Company Information
  81. 7.14.2 Aurobindo Pharma Business Overview
  82. 7.14.3 Aurobindo Pharma Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Aurobindo Pharma Teriflunomide Tablets Product Portfolio
  84. 7.14.5 Aurobindo Pharma Recent Developments
  85. 7.15 Apotex
  86. 7.15.1 Apotex Company Information
  87. 7.15.2 Apotex Business Overview
  88. 7.15.3 Apotex Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Apotex Teriflunomide Tablets Product Portfolio
  90. 7.15.5 Apotex Recent Developments
  91. 7.16 Alembic
  92. 7.16.1 Alembic Company Information
  93. 7.16.2 Alembic Business Overview
  94. 7.16.3 Alembic Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Alembic Teriflunomide Tablets Product Portfolio
  96. 7.16.5 Alembic Recent Developments
  97. 7.17 Accord Healthcare
  98. 7.17.1 Accord Healthcare Company Information
  99. 7.17.2 Accord Healthcare Business Overview
  100. 7.17.3 Accord Healthcare Teriflunomide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Accord Healthcare Teriflunomide Tablets Product Portfolio
  102. 7.17.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Teriflunomide Tablets Market Size by Type
  2. 8.1.1 North America Teriflunomide Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Teriflunomide Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Teriflunomide Tablets Price by Type (2021-2032)
  5. 8.2 North America Teriflunomide Tablets Market Size by Application
  6. 8.2.1 North America Teriflunomide Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Teriflunomide Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Teriflunomide Tablets Price by Application (2021-2032)
  9. 8.3 North America Teriflunomide Tablets Market Size by Country
  10. 8.3.1 North America Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Teriflunomide Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Teriflunomide Tablets Market Size by Type
  2. 9.1.1 Europe Teriflunomide Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Teriflunomide Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Teriflunomide Tablets Price by Type (2021-2032)
  5. 9.2 Europe Teriflunomide Tablets Market Size by Application
  6. 9.2.1 Europe Teriflunomide Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Teriflunomide Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Teriflunomide Tablets Price by Application (2021-2032)
  9. 9.3 Europe Teriflunomide Tablets Market Size by Country
  10. 9.3.1 Europe Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Teriflunomide Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Teriflunomide Tablets Market Size by Type
  2. 10.1.1 China Teriflunomide Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Teriflunomide Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Teriflunomide Tablets Price by Type (2021-2032)
  5. 10.2 China Teriflunomide Tablets Market Size by Application
  6. 10.2.1 China Teriflunomide Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Teriflunomide Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Teriflunomide Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Teriflunomide Tablets Market Size by Type
  2. 11.1.1 Asia Teriflunomide Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Teriflunomide Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Teriflunomide Tablets Price by Type (2021-2032)
  5. 11.2 Asia Teriflunomide Tablets Market Size by Application
  6. 11.2.1 Asia Teriflunomide Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Teriflunomide Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Teriflunomide Tablets Price by Application (2021-2032)
  9. 11.3 Asia Teriflunomide Tablets Market Size by Country
  10. 11.3.1 Asia Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Teriflunomide Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Teriflunomide Tablets Market Size by Type
  2. 12.1.1 SAMEA Teriflunomide Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Teriflunomide Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Teriflunomide Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Teriflunomide Tablets Market Size by Application
  6. 12.2.1 SAMEA Teriflunomide Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Teriflunomide Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Teriflunomide Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Teriflunomide Tablets Market Size by Country
  10. 12.3.1 SAMEA Teriflunomide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Teriflunomide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Teriflunomide Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Teriflunomide Tablets Value Chain Analysis
  2. 13.1.1 Teriflunomide Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Teriflunomide Tablets Production Mode & Process
  6. 13.2 Teriflunomide Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Teriflunomide Tablets Distributors
  9. 13.2.3 Teriflunomide Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst